Global X ETFs, the New York-based provider of exchange-traded funds, today announced the scheduled liquidation of the following ETFs (the "Funds"), based on an ongoing review process of its product lineup to ensure it meets the evolving needs of its clients. The Funds scheduled for liquidation include:

So far this month, Wall Street remained almost flat. But a few ETF areas have been hovering at around a month-high and have been still gaining strength.

Investing and trading cannabis stocks has been extraordinarily difficult. I feel for those who took a bet for all the right reasons (which we’ll get into). But the entire space has been incredibly challenged. If we look at the Global X Cannabis ETF (NASDAQ:POTX) as a proxy, it’s clear that investors have felt pain for a few years. But is there perhaps an opportunity in cannabis stocks now? Source: Charts by TradingView First, we should distinguish between cannabis dispensaries and companies tied

MARKET PULSE German health minister Karl Lauterbach has released the government's closely-watched proposal to legalize adult use cannabis. Lauterbach said the proposal must be confirmed that it complies with European Union and other international laws, according to reports of a press conference.

Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today announced a reverse split of the Global X Cannabis ETF (POTX) ("the Fund").

Dan Ahrens, Portfolio Manager of the AdvisorShares Pure Cannabis ETFs, sits down with Yahoo Finance Live to talk about the legal marijuana industry's growth, legalization prospects by state, and limited market development in Canada as compared to the U.S.

Pharmaceutical exchange-traded funds (ETFs) offer investors access to a basket of U.S.-based and foreign stocks of drug manufacturers and related companies in a single investment. These companies discover, develop, and produce medications used to cure disease, vaccinate, or alleviate symptoms of illness.

By Dhirendra Tripathi

After soaring to all-time highs last month, exchange traded funds tracking cannabis stocks are coming back down to test a key support line.

Pharmaceutical exchange-traded funds (ETFs) offer investors access to a basket of U.S.-based and foreign stocks of drug manufacturers and related companies in a single investment. These companies discover, develop, and produce medications used to cure disease, vaccinate, or alleviate symptoms of illness.